nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Temsirolimus—kidney cancer	0.138	0.22	CbGbCtD
Argatroban—CYP3A4—Everolimus—kidney cancer	0.0795	0.127	CbGbCtD
Argatroban—F2—posterior vena cava—kidney cancer	0.0639	0.624	CbGeAlD
Argatroban—CYP3A4—Temsirolimus—kidney cancer	0.0537	0.0859	CbGbCtD
Argatroban—CYP3A5—Erlotinib—kidney cancer	0.0516	0.0826	CbGbCtD
Argatroban—CYP3A5—Paclitaxel—kidney cancer	0.0473	0.0756	CbGbCtD
Argatroban—CYP3A5—Sorafenib—kidney cancer	0.042	0.0672	CbGbCtD
Argatroban—CYP3A5—Vincristine—kidney cancer	0.0408	0.0652	CbGbCtD
Argatroban—CYP3A5—Sunitinib—kidney cancer	0.034	0.0544	CbGbCtD
Argatroban—CYP3A4—Pazopanib—kidney cancer	0.0282	0.0451	CbGbCtD
Argatroban—CYP3A4—Erlotinib—kidney cancer	0.0201	0.0322	CbGbCtD
Argatroban—CYP3A4—Paclitaxel—kidney cancer	0.0184	0.0295	CbGbCtD
Argatroban—F2—urine—kidney cancer	0.0165	0.161	CbGeAlD
Argatroban—CYP3A4—Sorafenib—kidney cancer	0.0164	0.0262	CbGbCtD
Argatroban—CYP3A4—Vinblastine—kidney cancer	0.0162	0.0259	CbGbCtD
Argatroban—CYP3A4—Vincristine—kidney cancer	0.0159	0.0254	CbGbCtD
Argatroban—CYP3A4—Sunitinib—kidney cancer	0.0133	0.0212	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—kidney cancer	0.00994	0.0159	CbGbCtD
Argatroban—CYP3A4—urine—kidney cancer	0.00502	0.049	CbGeAlD
Argatroban—F2—renal system—kidney cancer	0.00404	0.0395	CbGeAlD
Argatroban—F2—kidney—kidney cancer	0.00391	0.0382	CbGeAlD
Argatroban—CYP3A5—nephron tubule—kidney cancer	0.0018	0.0176	CbGeAlD
Argatroban—CYP3A5—renal system—kidney cancer	0.00164	0.016	CbGeAlD
Argatroban—CYP3A5—kidney—kidney cancer	0.00158	0.0155	CbGeAlD
Argatroban—CYP3A5—cortex of kidney—kidney cancer	0.00154	0.015	CbGeAlD
Argatroban—CYP3A4—renal system—kidney cancer	0.00123	0.012	CbGeAlD
Argatroban—CYP3A4—kidney—kidney cancer	0.00119	0.0116	CbGeAlD
Argatroban—Cough—Sunitinib—kidney cancer	0.000384	0.00161	CcSEcCtD
Argatroban—Dyspnoea—Everolimus—kidney cancer	0.000384	0.00161	CcSEcCtD
Argatroban—Cardiac arrest—Capecitabine—kidney cancer	0.000383	0.00161	CcSEcCtD
Argatroban—Dizziness—Temsirolimus—kidney cancer	0.000383	0.00161	CcSEcCtD
Argatroban—Pneumonia—Paclitaxel—kidney cancer	0.000381	0.0016	CcSEcCtD
Argatroban—Dyspepsia—Everolimus—kidney cancer	0.000379	0.00159	CcSEcCtD
Argatroban—Chest pain—Sunitinib—kidney cancer	0.000375	0.00158	CcSEcCtD
Argatroban—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000373	0.00157	CcSEcCtD
Argatroban—Diarrhoea—Pazopanib—kidney cancer	0.000373	0.00157	CcSEcCtD
Argatroban—Gastrointestinal disorder—Everolimus—kidney cancer	0.000371	0.00156	CcSEcCtD
Argatroban—Myocardial infarction—Paclitaxel—kidney cancer	0.000371	0.00156	CcSEcCtD
Argatroban—Infection—Sorafenib—kidney cancer	0.000371	0.00156	CcSEcCtD
Argatroban—Dyspnoea—Erlotinib—kidney cancer	0.00037	0.00156	CcSEcCtD
Argatroban—Pain—Vinblastine—kidney cancer	0.000369	0.00155	CcSEcCtD
Argatroban—Constipation—Vinblastine—kidney cancer	0.000369	0.00155	CcSEcCtD
Argatroban—Angiopathy—Gemcitabine—kidney cancer	0.000368	0.00155	CcSEcCtD
Argatroban—Urinary tract infection—Paclitaxel—kidney cancer	0.000368	0.00155	CcSEcCtD
Argatroban—Pain—Everolimus—kidney cancer	0.000368	0.00155	CcSEcCtD
Argatroban—Constipation—Everolimus—kidney cancer	0.000368	0.00155	CcSEcCtD
Argatroban—Vomiting—Temsirolimus—kidney cancer	0.000368	0.00155	CcSEcCtD
Argatroban—Dyspepsia—Erlotinib—kidney cancer	0.000365	0.00154	CcSEcCtD
Argatroban—Rash—Temsirolimus—kidney cancer	0.000365	0.00153	CcSEcCtD
Argatroban—Dermatitis—Temsirolimus—kidney cancer	0.000364	0.00153	CcSEcCtD
Argatroban—Headache—Temsirolimus—kidney cancer	0.000362	0.00152	CcSEcCtD
Argatroban—Haematuria—Paclitaxel—kidney cancer	0.000361	0.00152	CcSEcCtD
Argatroban—Dizziness—Pazopanib—kidney cancer	0.00036	0.00151	CcSEcCtD
Argatroban—Back pain—Vincristine—kidney cancer	0.00036	0.00151	CcSEcCtD
Argatroban—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000358	0.00151	CcSEcCtD
Argatroban—Ventricular tachycardia—Doxorubicin—kidney cancer	0.000358	0.0015	CcSEcCtD
Argatroban—Pulmonary embolism—Doxorubicin—kidney cancer	0.000358	0.0015	CcSEcCtD
Argatroban—Infection—Sunitinib—kidney cancer	0.000357	0.0015	CcSEcCtD
Argatroban—Feeling abnormal—Vinblastine—kidney cancer	0.000356	0.0015	CcSEcCtD
Argatroban—Constipation—Erlotinib—kidney cancer	0.000355	0.00149	CcSEcCtD
Argatroban—Pain—Erlotinib—kidney cancer	0.000355	0.00149	CcSEcCtD
Argatroban—Feeling abnormal—Everolimus—kidney cancer	0.000355	0.00149	CcSEcCtD
Argatroban—Gastrointestinal pain—Vinblastine—kidney cancer	0.000353	0.00148	CcSEcCtD
Argatroban—Gastrointestinal pain—Everolimus—kidney cancer	0.000352	0.00148	CcSEcCtD
Argatroban—Vomiting—Pazopanib—kidney cancer	0.000346	0.00146	CcSEcCtD
Argatroban—Bradycardia—Paclitaxel—kidney cancer	0.000346	0.00145	CcSEcCtD
Argatroban—Rash—Pazopanib—kidney cancer	0.000344	0.00144	CcSEcCtD
Argatroban—Nausea—Temsirolimus—kidney cancer	0.000344	0.00144	CcSEcCtD
Argatroban—Dermatitis—Pazopanib—kidney cancer	0.000343	0.00144	CcSEcCtD
Argatroban—Back pain—Gemcitabine—kidney cancer	0.000342	0.00144	CcSEcCtD
Argatroban—Haemoglobin—Paclitaxel—kidney cancer	0.000342	0.00144	CcSEcCtD
Argatroban—Abdominal pain—Vinblastine—kidney cancer	0.000341	0.00143	CcSEcCtD
Argatroban—Headache—Pazopanib—kidney cancer	0.000341	0.00143	CcSEcCtD
Argatroban—Abdominal pain—Everolimus—kidney cancer	0.00034	0.00143	CcSEcCtD
Argatroban—Body temperature increased—Everolimus—kidney cancer	0.00034	0.00143	CcSEcCtD
Argatroban—Haemorrhage—Paclitaxel—kidney cancer	0.00034	0.00143	CcSEcCtD
Argatroban—Gastrointestinal pain—Erlotinib—kidney cancer	0.000339	0.00143	CcSEcCtD
Argatroban—Angina pectoris—Capecitabine—kidney cancer	0.000339	0.00143	CcSEcCtD
Argatroban—Infection—Dactinomycin—kidney cancer	0.000338	0.00142	CcSEcCtD
Argatroban—Dyspnoea—Sorafenib—kidney cancer	0.000333	0.0014	CcSEcCtD
Argatroban—Dyspepsia—Sorafenib—kidney cancer	0.000329	0.00138	CcSEcCtD
Argatroban—Body temperature increased—Erlotinib—kidney cancer	0.000328	0.00138	CcSEcCtD
Argatroban—Abdominal pain—Erlotinib—kidney cancer	0.000328	0.00138	CcSEcCtD
Argatroban—Nausea—Pazopanib—kidney cancer	0.000324	0.00136	CcSEcCtD
Argatroban—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000322	0.00135	CcSEcCtD
Argatroban—Dyspnoea—Sunitinib—kidney cancer	0.00032	0.00135	CcSEcCtD
Argatroban—Constipation—Sorafenib—kidney cancer	0.000319	0.00134	CcSEcCtD
Argatroban—Pain—Sorafenib—kidney cancer	0.000319	0.00134	CcSEcCtD
Argatroban—Pulmonary oedema—Doxorubicin—kidney cancer	0.000319	0.00134	CcSEcCtD
Argatroban—Hypersensitivity—Vinblastine—kidney cancer	0.000318	0.00134	CcSEcCtD
Argatroban—Hypersensitivity—Everolimus—kidney cancer	0.000317	0.00133	CcSEcCtD
Argatroban—Dyspepsia—Sunitinib—kidney cancer	0.000316	0.00133	CcSEcCtD
Argatroban—Pneumonia—Capecitabine—kidney cancer	0.000312	0.00131	CcSEcCtD
Argatroban—Sepsis—Doxorubicin—kidney cancer	0.000311	0.00131	CcSEcCtD
Argatroban—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00031	0.0013	CcSEcCtD
Argatroban—Cough—Gemcitabine—kidney cancer	0.000308	0.0013	CcSEcCtD
Argatroban—Angiopathy—Paclitaxel—kidney cancer	0.000308	0.0013	CcSEcCtD
Argatroban—Constipation—Sunitinib—kidney cancer	0.000307	0.00129	CcSEcCtD
Argatroban—Pain—Sunitinib—kidney cancer	0.000307	0.00129	CcSEcCtD
Argatroban—Acute coronary syndrome—Capecitabine—kidney cancer	0.000306	0.00129	CcSEcCtD
Argatroban—Gastrointestinal pain—Sorafenib—kidney cancer	0.000305	0.00128	CcSEcCtD
Argatroban—Myocardial infarction—Capecitabine—kidney cancer	0.000305	0.00128	CcSEcCtD
Argatroban—Infection—Vincristine—kidney cancer	0.000302	0.00127	CcSEcCtD
Argatroban—Urinary tract infection—Capecitabine—kidney cancer	0.000302	0.00127	CcSEcCtD
Argatroban—Chest pain—Gemcitabine—kidney cancer	0.000301	0.00126	CcSEcCtD
Argatroban—Thrombophlebitis—Doxorubicin—kidney cancer	0.0003	0.00126	CcSEcCtD
Argatroban—Haematuria—Capecitabine—kidney cancer	0.000296	0.00124	CcSEcCtD
Argatroban—Diarrhoea—Vinblastine—kidney cancer	0.000296	0.00124	CcSEcCtD
Argatroban—Abdominal pain—Sorafenib—kidney cancer	0.000295	0.00124	CcSEcCtD
Argatroban—Body temperature increased—Sorafenib—kidney cancer	0.000295	0.00124	CcSEcCtD
Argatroban—Diarrhoea—Everolimus—kidney cancer	0.000294	0.00124	CcSEcCtD
Argatroban—Gastrointestinal pain—Sunitinib—kidney cancer	0.000294	0.00123	CcSEcCtD
Argatroban—Pain—Dactinomycin—kidney cancer	0.000291	0.00122	CcSEcCtD
Argatroban—Infection—Gemcitabine—kidney cancer	0.000286	0.0012	CcSEcCtD
Argatroban—Back pain—Paclitaxel—kidney cancer	0.000286	0.0012	CcSEcCtD
Argatroban—Dizziness—Vinblastine—kidney cancer	0.000286	0.0012	CcSEcCtD
Argatroban—Dizziness—Everolimus—kidney cancer	0.000285	0.0012	CcSEcCtD
Argatroban—Abdominal pain—Sunitinib—kidney cancer	0.000284	0.00119	CcSEcCtD
Argatroban—Body temperature increased—Sunitinib—kidney cancer	0.000284	0.00119	CcSEcCtD
Argatroban—Diarrhoea—Erlotinib—kidney cancer	0.000284	0.00119	CcSEcCtD
Argatroban—Hypotension—Vincristine—kidney cancer	0.000284	0.00119	CcSEcCtD
Argatroban—Bradycardia—Capecitabine—kidney cancer	0.000284	0.00119	CcSEcCtD
Argatroban—Renal failure acute—Doxorubicin—kidney cancer	0.000281	0.00118	CcSEcCtD
Argatroban—Feeling abnormal—Dactinomycin—kidney cancer	0.00028	0.00118	CcSEcCtD
Argatroban—Haemoglobin—Capecitabine—kidney cancer	0.00028	0.00118	CcSEcCtD
Argatroban—Haemorrhage—Capecitabine—kidney cancer	0.000279	0.00117	CcSEcCtD
Argatroban—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000278	0.00117	CcSEcCtD
Argatroban—Hypersensitivity—Sorafenib—kidney cancer	0.000275	0.00116	CcSEcCtD
Argatroban—Vomiting—Vinblastine—kidney cancer	0.000275	0.00115	CcSEcCtD
Argatroban—Dizziness—Erlotinib—kidney cancer	0.000275	0.00115	CcSEcCtD
Argatroban—Vomiting—Everolimus—kidney cancer	0.000274	0.00115	CcSEcCtD
Argatroban—Renal impairment—Doxorubicin—kidney cancer	0.000273	0.00115	CcSEcCtD
Argatroban—Dermatitis bullous—Doxorubicin—kidney cancer	0.000272	0.00114	CcSEcCtD
Argatroban—Rash—Everolimus—kidney cancer	0.000271	0.00114	CcSEcCtD
Argatroban—Dermatitis—Everolimus—kidney cancer	0.000271	0.00114	CcSEcCtD
Argatroban—Headache—Vinblastine—kidney cancer	0.000271	0.00114	CcSEcCtD
Argatroban—Headache—Everolimus—kidney cancer	0.00027	0.00113	CcSEcCtD
Argatroban—Hypotension—Gemcitabine—kidney cancer	0.000269	0.00113	CcSEcCtD
Argatroban—Abdominal pain—Dactinomycin—kidney cancer	0.000269	0.00113	CcSEcCtD
Argatroban—Body temperature increased—Dactinomycin—kidney cancer	0.000269	0.00113	CcSEcCtD
Argatroban—Cardiac failure—Doxorubicin—kidney cancer	0.000266	0.00112	CcSEcCtD
Argatroban—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000265	0.00111	CcSEcCtD
Argatroban—Hypersensitivity—Sunitinib—kidney cancer	0.000265	0.00111	CcSEcCtD
Argatroban—Vomiting—Erlotinib—kidney cancer	0.000264	0.00111	CcSEcCtD
Argatroban—Gastrointestinal disorder—Vincristine—kidney cancer	0.000262	0.0011	CcSEcCtD
Argatroban—Rash—Erlotinib—kidney cancer	0.000262	0.0011	CcSEcCtD
Argatroban—Dermatitis—Erlotinib—kidney cancer	0.000262	0.0011	CcSEcCtD
Argatroban—Headache—Erlotinib—kidney cancer	0.00026	0.00109	CcSEcCtD
Argatroban—Pain—Vincristine—kidney cancer	0.00026	0.00109	CcSEcCtD
Argatroban—Constipation—Vincristine—kidney cancer	0.00026	0.00109	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00026	0.00109	CcSEcCtD
Argatroban—Cough—Paclitaxel—kidney cancer	0.000258	0.00108	CcSEcCtD
Argatroban—Dyspnoea—Gemcitabine—kidney cancer	0.000257	0.00108	CcSEcCtD
Argatroban—Nausea—Vinblastine—kidney cancer	0.000257	0.00108	CcSEcCtD
Argatroban—Nausea—Everolimus—kidney cancer	0.000256	0.00107	CcSEcCtD
Argatroban—Diarrhoea—Sorafenib—kidney cancer	0.000256	0.00107	CcSEcCtD
Argatroban—Angiopathy—Capecitabine—kidney cancer	0.000253	0.00106	CcSEcCtD
Argatroban—Chest pain—Paclitaxel—kidney cancer	0.000252	0.00106	CcSEcCtD
Argatroban—Hypersensitivity—Dactinomycin—kidney cancer	0.000251	0.00105	CcSEcCtD
Argatroban—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000249	0.00105	CcSEcCtD
Argatroban—Gastrointestinal pain—Vincristine—kidney cancer	0.000249	0.00104	CcSEcCtD
Argatroban—Cardiac arrest—Doxorubicin—kidney cancer	0.000247	0.00104	CcSEcCtD
Argatroban—Dizziness—Sorafenib—kidney cancer	0.000247	0.00104	CcSEcCtD
Argatroban—Pain—Gemcitabine—kidney cancer	0.000247	0.00104	CcSEcCtD
Argatroban—Constipation—Gemcitabine—kidney cancer	0.000247	0.00104	CcSEcCtD
Argatroban—Nausea—Erlotinib—kidney cancer	0.000247	0.00104	CcSEcCtD
Argatroban—Diarrhoea—Sunitinib—kidney cancer	0.000246	0.00103	CcSEcCtD
Argatroban—Confusional state—Paclitaxel—kidney cancer	0.000243	0.00102	CcSEcCtD
Argatroban—Abdominal pain—Vincristine—kidney cancer	0.00024	0.00101	CcSEcCtD
Argatroban—Body temperature increased—Vincristine—kidney cancer	0.00024	0.00101	CcSEcCtD
Argatroban—Infection—Paclitaxel—kidney cancer	0.00024	0.00101	CcSEcCtD
Argatroban—Dizziness—Sunitinib—kidney cancer	0.000238	0.000999	CcSEcCtD
Argatroban—Feeling abnormal—Gemcitabine—kidney cancer	0.000238	0.000999	CcSEcCtD
Argatroban—Vomiting—Sorafenib—kidney cancer	0.000237	0.000998	CcSEcCtD
Argatroban—Tachycardia—Paclitaxel—kidney cancer	0.000236	0.00099	CcSEcCtD
Argatroban—Rash—Sorafenib—kidney cancer	0.000235	0.00099	CcSEcCtD
Argatroban—Dermatitis—Sorafenib—kidney cancer	0.000235	0.000989	CcSEcCtD
Argatroban—Back pain—Capecitabine—kidney cancer	0.000235	0.000987	CcSEcCtD
Argatroban—Headache—Sorafenib—kidney cancer	0.000234	0.000983	CcSEcCtD
Argatroban—Diarrhoea—Dactinomycin—kidney cancer	0.000233	0.000978	CcSEcCtD
Argatroban—Vomiting—Sunitinib—kidney cancer	0.000229	0.00096	CcSEcCtD
Argatroban—Body temperature increased—Gemcitabine—kidney cancer	0.000228	0.000958	CcSEcCtD
Argatroban—Rash—Sunitinib—kidney cancer	0.000227	0.000952	CcSEcCtD
Argatroban—Dermatitis—Sunitinib—kidney cancer	0.000226	0.000951	CcSEcCtD
Argatroban—Hypotension—Paclitaxel—kidney cancer	0.000226	0.000948	CcSEcCtD
Argatroban—Headache—Sunitinib—kidney cancer	0.000225	0.000946	CcSEcCtD
Argatroban—Hypersensitivity—Vincristine—kidney cancer	0.000224	0.000941	CcSEcCtD
Argatroban—Nausea—Sorafenib—kidney cancer	0.000222	0.000932	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000222	0.00643	CbGpPWpGaD
Argatroban—F2—Hemostasis—L1CAM—kidney cancer	0.00022	0.00637	CbGpPWpGaD
Argatroban—Angina pectoris—Doxorubicin—kidney cancer	0.000219	0.000919	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000217	0.00629	CbGpPWpGaD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000216	0.00628	CbGpPWpGaD
Argatroban—Vomiting—Dactinomycin—kidney cancer	0.000216	0.000909	CcSEcCtD
Argatroban—Dyspnoea—Paclitaxel—kidney cancer	0.000215	0.000905	CcSEcCtD
Argatroban—Rash—Dactinomycin—kidney cancer	0.000215	0.000901	CcSEcCtD
Argatroban—Nausea—Sunitinib—kidney cancer	0.000213	0.000897	CcSEcCtD
Argatroban—Dyspepsia—Paclitaxel—kidney cancer	0.000213	0.000893	CcSEcCtD
Argatroban—Cough—Capecitabine—kidney cancer	0.000212	0.00089	CcSEcCtD
Argatroban—F2—Metabolism of proteins—EIF5B—kidney cancer	0.000212	0.00614	CbGpPWpGaD
Argatroban—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000209	0.00606	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000208	0.000876	CcSEcCtD
Argatroban—Diarrhoea—Vincristine—kidney cancer	0.000208	0.000874	CcSEcCtD
Argatroban—F2—G alpha (q) signalling events—ANXA1—kidney cancer	0.000208	0.00603	CbGpPWpGaD
Argatroban—Chest pain—Capecitabine—kidney cancer	0.000207	0.000869	CcSEcCtD
Argatroban—Constipation—Paclitaxel—kidney cancer	0.000206	0.000868	CcSEcCtD
Argatroban—Pain—Paclitaxel—kidney cancer	0.000206	0.000868	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.000205	0.00595	CbGpPWpGaD
Argatroban—Nausea—Dactinomycin—kidney cancer	0.000202	0.000849	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—kidney cancer	0.000201	0.000846	CcSEcCtD
Argatroban—Dizziness—Vincristine—kidney cancer	0.000201	0.000845	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000201	0.00582	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—OR4C13—kidney cancer	0.0002	0.00581	CbGpPWpGaD
Argatroban—Confusional state—Capecitabine—kidney cancer	0.0002	0.000839	CcSEcCtD
Argatroban—Feeling abnormal—Paclitaxel—kidney cancer	0.000199	0.000836	CcSEcCtD
Argatroban—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000197	0.00083	CcSEcCtD
Argatroban—Diarrhoea—Gemcitabine—kidney cancer	0.000197	0.000829	CcSEcCtD
Argatroban—Infection—Capecitabine—kidney cancer	0.000197	0.000827	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000196	0.0057	CbGpPWpGaD
Argatroban—Urinary tract infection—Doxorubicin—kidney cancer	0.000195	0.000818	CcSEcCtD
Argatroban—Tachycardia—Capecitabine—kidney cancer	0.000193	0.000813	CcSEcCtD
Argatroban—Vomiting—Vincristine—kidney cancer	0.000193	0.000812	CcSEcCtD
Argatroban—F2—Folate Metabolism—RELA—kidney cancer	0.000192	0.00558	CbGpPWpGaD
Argatroban—Rash—Vincristine—kidney cancer	0.000192	0.000805	CcSEcCtD
Argatroban—Dermatitis—Vincristine—kidney cancer	0.000191	0.000805	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—kidney cancer	0.000191	0.000802	CcSEcCtD
Argatroban—Abdominal pain—Paclitaxel—kidney cancer	0.000191	0.000802	CcSEcCtD
Argatroban—Body temperature increased—Paclitaxel—kidney cancer	0.000191	0.000802	CcSEcCtD
Argatroban—Headache—Vincristine—kidney cancer	0.00019	0.0008	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.00019	0.00552	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—ALDH1A1—kidney cancer	0.00019	0.0055	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CUL7—kidney cancer	0.000189	0.00548	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000186	0.00539	CbGpPWpGaD
Argatroban—Hypotension—Capecitabine—kidney cancer	0.000185	0.000778	CcSEcCtD
Argatroban—Vomiting—Gemcitabine—kidney cancer	0.000183	0.00077	CcSEcCtD
Argatroban—Bradycardia—Doxorubicin—kidney cancer	0.000183	0.000769	CcSEcCtD
Argatroban—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000182	0.00528	CbGpPWpGaD
Argatroban—Rash—Gemcitabine—kidney cancer	0.000182	0.000764	CcSEcCtD
Argatroban—F2—Signaling by GPCR—OR4C13—kidney cancer	0.000182	0.00527	CbGpPWpGaD
Argatroban—Dermatitis—Gemcitabine—kidney cancer	0.000182	0.000763	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—kidney cancer	0.000181	0.000759	CcSEcCtD
Argatroban—Headache—Gemcitabine—kidney cancer	0.000181	0.000759	CcSEcCtD
Argatroban—Nausea—Vincristine—kidney cancer	0.000181	0.000759	CcSEcCtD
Argatroban—F2—Metabolism of proteins—HSPA9—kidney cancer	0.00018	0.00522	CbGpPWpGaD
Argatroban—Haemorrhage—Doxorubicin—kidney cancer	0.00018	0.000755	CcSEcCtD
Argatroban—Hypersensitivity—Paclitaxel—kidney cancer	0.000178	0.000747	CcSEcCtD
Argatroban—Dyspnoea—Capecitabine—kidney cancer	0.000177	0.000742	CcSEcCtD
Argatroban—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000175	0.00507	CbGpPWpGaD
Argatroban—Dyspepsia—Capecitabine—kidney cancer	0.000174	0.000733	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK3—kidney cancer	0.000174	0.00504	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL2—kidney cancer	0.000173	0.00502	CbGpPWpGaD
Argatroban—Nausea—Gemcitabine—kidney cancer	0.000171	0.00072	CcSEcCtD
Argatroban—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000171	0.000719	CcSEcCtD
Argatroban—Pain—Capecitabine—kidney cancer	0.000169	0.000712	CcSEcCtD
Argatroban—Constipation—Capecitabine—kidney cancer	0.000169	0.000712	CcSEcCtD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000168	0.00488	CbGpPWpGaD
Argatroban—F2—Hemostasis—ANXA2—kidney cancer	0.000166	0.00483	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000166	0.00481	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—kidney cancer	0.000165	0.0048	CbGpPWpGaD
Argatroban—Diarrhoea—Paclitaxel—kidney cancer	0.000165	0.000694	CcSEcCtD
Argatroban—Feeling abnormal—Capecitabine—kidney cancer	0.000163	0.000686	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—kidney cancer	0.000163	0.000685	CcSEcCtD
Argatroban—Gastrointestinal pain—Capecitabine—kidney cancer	0.000162	0.000681	CcSEcCtD
Argatroban—F2—PAR1-mediated thrombin signaling events—PIK3CA—kidney cancer	0.000162	0.0047	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000161	0.00466	CbGpPWpGaD
Argatroban—Dizziness—Paclitaxel—kidney cancer	0.00016	0.000671	CcSEcCtD
Argatroban—Abdominal pain—Capecitabine—kidney cancer	0.000157	0.000658	CcSEcCtD
Argatroban—Body temperature increased—Capecitabine—kidney cancer	0.000157	0.000658	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000156	0.00453	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000154	0.00447	CbGpPWpGaD
Argatroban—Vomiting—Paclitaxel—kidney cancer	0.000154	0.000645	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—RELA—kidney cancer	0.000153	0.00443	CbGpPWpGaD
Argatroban—Rash—Paclitaxel—kidney cancer	0.000152	0.00064	CcSEcCtD
Argatroban—Dermatitis—Paclitaxel—kidney cancer	0.000152	0.000639	CcSEcCtD
Argatroban—Back pain—Doxorubicin—kidney cancer	0.000151	0.000636	CcSEcCtD
Argatroban—Headache—Paclitaxel—kidney cancer	0.000151	0.000636	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000148	0.0043	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MUC4—kidney cancer	0.000147	0.00426	CbGpPWpGaD
Argatroban—Hypersensitivity—Capecitabine—kidney cancer	0.000146	0.000613	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—kidney cancer	0.000144	0.00416	CbGpPWpGaD
Argatroban—Nausea—Paclitaxel—kidney cancer	0.000143	0.000603	CcSEcCtD
Argatroban—F2—Metabolism of proteins—ST3GAL2—kidney cancer	0.00014	0.00405	CbGpPWpGaD
Argatroban—F2—Hemostasis—KCNMA1—kidney cancer	0.000138	0.004	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000138	0.00399	CbGpPWpGaD
Argatroban—Cough—Doxorubicin—kidney cancer	0.000137	0.000574	CcSEcCtD
Argatroban—F2—Metabolism of proteins—EEF2—kidney cancer	0.000137	0.00396	CbGpPWpGaD
Argatroban—Diarrhoea—Capecitabine—kidney cancer	0.000136	0.00057	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000133	0.00387	CbGpPWpGaD
Argatroban—Chest pain—Doxorubicin—kidney cancer	0.000133	0.00056	CcSEcCtD
Argatroban—Dizziness—Capecitabine—kidney cancer	0.000131	0.000551	CcSEcCtD
Argatroban—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00013	0.00378	CbGpPWpGaD
Argatroban—Confusional state—Doxorubicin—kidney cancer	0.000129	0.000541	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—APC—kidney cancer	0.000128	0.00372	CbGpPWpGaD
Argatroban—Infection—Doxorubicin—kidney cancer	0.000127	0.000533	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000127	0.00367	CbGpPWpGaD
Argatroban—Vomiting—Capecitabine—kidney cancer	0.000126	0.000529	CcSEcCtD
Argatroban—Rash—Capecitabine—kidney cancer	0.000125	0.000525	CcSEcCtD
Argatroban—Dermatitis—Capecitabine—kidney cancer	0.000125	0.000524	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—kidney cancer	0.000125	0.000524	CcSEcCtD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000124	0.0036	CbGpPWpGaD
Argatroban—Headache—Capecitabine—kidney cancer	0.000124	0.000522	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—BRAF—kidney cancer	0.000121	0.0035	CbGpPWpGaD
Argatroban—F2—Hemostasis—GRB7—kidney cancer	0.00012	0.00349	CbGpPWpGaD
Argatroban—Hypotension—Doxorubicin—kidney cancer	0.000119	0.000501	CcSEcCtD
Argatroban—Nausea—Capecitabine—kidney cancer	0.000118	0.000495	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000116	0.00338	CbGpPWpGaD
Argatroban—Dyspnoea—Doxorubicin—kidney cancer	0.000114	0.000478	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—kidney cancer	0.000112	0.000472	CcSEcCtD
Argatroban—F2—Hemostasis—ITPR2—kidney cancer	0.000112	0.00324	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTT1—kidney cancer	0.000111	0.00323	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—kidney cancer	0.000111	0.00322	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00011	0.000463	CcSEcCtD
Argatroban—Constipation—Doxorubicin—kidney cancer	0.000109	0.000459	CcSEcCtD
Argatroban—Pain—Doxorubicin—kidney cancer	0.000109	0.000459	CcSEcCtD
Argatroban—F2—Signaling Pathways—OR4C13—kidney cancer	0.000107	0.00311	CbGpPWpGaD
Argatroban—Feeling abnormal—Doxorubicin—kidney cancer	0.000105	0.000442	CcSEcCtD
Argatroban—F2—GPCR ligand binding—ANXA1—kidney cancer	0.000105	0.00304	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MME—kidney cancer	0.000105	0.00303	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000104	0.000439	CcSEcCtD
Argatroban—CYP3A5—Biological oxidations—PTGS1—kidney cancer	0.000104	0.00303	CbGpPWpGaD
Argatroban—Abdominal pain—Doxorubicin—kidney cancer	0.000101	0.000424	CcSEcCtD
Argatroban—Body temperature increased—Doxorubicin—kidney cancer	0.000101	0.000424	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—RAF1—kidney cancer	0.000101	0.00292	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—POMC—kidney cancer	0.000101	0.00292	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—HSPD1—kidney cancer	9.73e-05	0.00282	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—RPL14—kidney cancer	9.73e-05	0.00282	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.44e-05	0.00274	CbGpPWpGaD
Argatroban—Hypersensitivity—Doxorubicin—kidney cancer	9.41e-05	0.000395	CcSEcCtD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	9.13e-05	0.00265	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LATS1—kidney cancer	9.13e-05	0.00265	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—KRAS—kidney cancer	9.04e-05	0.00262	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	8.98e-05	0.0026	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	8.81e-05	0.00256	CbGpPWpGaD
Argatroban—Diarrhoea—Doxorubicin—kidney cancer	8.74e-05	0.000367	CcSEcCtD
Argatroban—Dizziness—Doxorubicin—kidney cancer	8.45e-05	0.000355	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—AKAP13—kidney cancer	8.31e-05	0.00241	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	8.31e-05	0.00241	CbGpPWpGaD
Argatroban—F2—Hemostasis—IFNA1—kidney cancer	8.21e-05	0.00238	CbGpPWpGaD
Argatroban—Vomiting—Doxorubicin—kidney cancer	8.12e-05	0.000341	CcSEcCtD
Argatroban—Rash—Doxorubicin—kidney cancer	8.05e-05	0.000338	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—kidney cancer	8.05e-05	0.000338	CcSEcCtD
Argatroban—F2—Metabolism of proteins—ACHE—kidney cancer	8.02e-05	0.00233	CbGpPWpGaD
Argatroban—Headache—Doxorubicin—kidney cancer	8e-05	0.000336	CcSEcCtD
Argatroban—F2—Metabolism of proteins—EIF4EBP1—kidney cancer	7.93e-05	0.0023	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AMER1—kidney cancer	7.76e-05	0.00225	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTP1—kidney cancer	7.72e-05	0.00224	CbGpPWpGaD
Argatroban—F2—Hemostasis—IFNA2—kidney cancer	7.64e-05	0.00222	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—PAX6—kidney cancer	7.63e-05	0.00221	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	7.61e-05	0.00221	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTSD—kidney cancer	7.59e-05	0.0022	CbGpPWpGaD
Argatroban—Nausea—Doxorubicin—kidney cancer	7.59e-05	0.000319	CcSEcCtD
Argatroban—F2—Signaling by GPCR—AKAP13—kidney cancer	7.55e-05	0.00219	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	7.51e-05	0.00218	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—RAF1—kidney cancer	7.34e-05	0.00213	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.26e-05	0.00211	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	7.26e-05	0.0021	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.17e-05	0.00208	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—kidney cancer	7.09e-05	0.00206	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ITPR2—kidney cancer	7.07e-05	0.00205	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	7e-05	0.00203	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—BCHE—kidney cancer	6.99e-05	0.00203	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	6.9e-05	0.002	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF2—kidney cancer	6.88e-05	0.00199	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	6.74e-05	0.00196	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	6.73e-05	0.00195	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	6.63e-05	0.00192	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—kidney cancer	6.58e-05	0.00191	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	6.52e-05	0.00189	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GPC3—kidney cancer	6.5e-05	0.00189	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CER1—kidney cancer	6.5e-05	0.00189	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ITPR2—kidney cancer	6.42e-05	0.00186	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	5.99e-05	0.00174	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ANXA1—kidney cancer	5.92e-05	0.00172	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACY1—kidney cancer	5.92e-05	0.00172	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.89e-05	0.00171	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	5.6e-05	0.00162	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SFRP2—kidney cancer	5.53e-05	0.0016	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.41e-05	0.00157	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	5.41e-05	0.00157	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF2—kidney cancer	5.41e-05	0.00157	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ANXA1—kidney cancer	5.38e-05	0.00156	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	5.29e-05	0.00154	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5.18e-05	0.0015	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	5.15e-05	0.00149	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—POMC—kidney cancer	5.13e-05	0.00149	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	5.04e-05	0.00146	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PDHB—kidney cancer	5.03e-05	0.00146	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—POMC—kidney cancer	5.01e-05	0.00145	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—kidney cancer	5e-05	0.00145	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	4.86e-05	0.00141	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.85e-05	0.00141	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CCBL1—kidney cancer	4.73e-05	0.00137	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	4.47e-05	0.0013	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKAP13—kidney cancer	4.46e-05	0.00129	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP2—kidney cancer	4.46e-05	0.00129	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.39e-05	0.00127	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	4.37e-05	0.00127	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPAT—kidney cancer	4.1e-05	0.00119	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GLIPR1—kidney cancer	4.1e-05	0.00119	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRB7—kidney cancer	4.08e-05	0.00118	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FH—kidney cancer	3.81e-05	0.00111	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APRT—kidney cancer	3.81e-05	0.00111	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITPR2—kidney cancer	3.79e-05	0.0011	CbGpPWpGaD
Argatroban—F2—Hemostasis—RAF1—kidney cancer	3.79e-05	0.0011	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—POMC—kidney cancer	3.61e-05	0.00105	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.59e-05	0.00104	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPC3—kidney cancer	3.58e-05	0.00104	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.54e-05	0.00103	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA2—kidney cancer	3.49e-05	0.00101	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNA1—kidney cancer	3.44e-05	0.000997	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EIF4EBP1—kidney cancer	3.42e-05	0.000991	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HSPB1—kidney cancer	3.42e-05	0.000991	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALAD—kidney cancer	3.4e-05	0.000986	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—kidney cancer	3.39e-05	0.000984	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ST3GAL2—kidney cancer	3.32e-05	0.000962	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.3e-05	0.000957	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.25e-05	0.000944	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALDH1A1—kidney cancer	3.24e-05	0.00094	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ANXA1—kidney cancer	3.18e-05	0.000921	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TSC1—kidney cancer	3.18e-05	0.000921	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PSMD7—kidney cancer	3.18e-05	0.000921	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.13e-05	0.000907	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PGK1—kidney cancer	3.11e-05	0.000901	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A3—kidney cancer	3.11e-05	0.000901	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.08e-05	0.000894	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FLT1—kidney cancer	3.08e-05	0.000892	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LDHB—kidney cancer	3.05e-05	0.000884	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—POMC—kidney cancer	2.9e-05	0.000841	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—kidney cancer	2.88e-05	0.000837	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PAK1—kidney cancer	2.85e-05	0.000827	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JUNB—kidney cancer	2.85e-05	0.000827	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACY1—kidney cancer	2.75e-05	0.000798	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK3—kidney cancer	2.73e-05	0.000791	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA9—kidney cancer	2.64e-05	0.000766	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—POMC—kidney cancer	2.63e-05	0.000764	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK1—kidney cancer	2.6e-05	0.000753	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—kidney cancer	2.58e-05	0.000748	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—kidney cancer	2.45e-05	0.000711	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PDHB—kidney cancer	2.34e-05	0.000678	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF2—kidney cancer	2.33e-05	0.000676	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—POMC—kidney cancer	2.33e-05	0.000676	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN2B—kidney cancer	2.32e-05	0.000673	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1R—kidney cancer	2.25e-05	0.000654	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—kidney cancer	2.25e-05	0.000653	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CRABP1—kidney cancer	2.25e-05	0.000652	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CCBL1—kidney cancer	2.2e-05	0.000638	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—kidney cancer	2.18e-05	0.000632	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—RAF1—kidney cancer	2.17e-05	0.00063	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—kidney cancer	2.14e-05	0.000622	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ITPR2—kidney cancer	2.09e-05	0.000606	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—kidney cancer	1.95e-05	0.000565	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.91e-05	0.000553	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPAT—kidney cancer	1.91e-05	0.000553	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—kidney cancer	1.9e-05	0.000552	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACHE—kidney cancer	1.9e-05	0.000552	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—kidney cancer	1.86e-05	0.000538	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TSC2—kidney cancer	1.85e-05	0.000537	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SCARB1—kidney cancer	1.8e-05	0.000523	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS1—kidney cancer	1.78e-05	0.000518	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—kidney cancer	1.77e-05	0.000515	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APRT—kidney cancer	1.77e-05	0.000514	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FH—kidney cancer	1.77e-05	0.000514	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMD7—kidney cancer	1.75e-05	0.000508	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPC3—kidney cancer	1.67e-05	0.000483	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BCHE—kidney cancer	1.66e-05	0.000481	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000475	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—kidney cancer	1.63e-05	0.000474	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KIT—kidney cancer	1.63e-05	0.000474	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA2—kidney cancer	1.62e-05	0.00047	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000459	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALAD—kidney cancer	1.58e-05	0.000458	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK3—kidney cancer	1.57e-05	0.000454	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—POMC—kidney cancer	1.56e-05	0.000451	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.54e-05	0.000447	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BRAF—kidney cancer	1.54e-05	0.000446	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.51e-05	0.000437	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK1—kidney cancer	1.49e-05	0.000432	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PGK1—kidney cancer	1.44e-05	0.000419	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.44e-05	0.000419	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—kidney cancer	1.42e-05	0.000413	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LDHB—kidney cancer	1.42e-05	0.000411	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—kidney cancer	1.41e-05	0.000408	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—kidney cancer	1.32e-05	0.000383	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—kidney cancer	1.29e-05	0.000375	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RAF1—kidney cancer	1.28e-05	0.000372	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RELA—kidney cancer	1.28e-05	0.000371	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB2—kidney cancer	1.27e-05	0.000368	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MTOR—kidney cancer	1.25e-05	0.000363	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000362	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA9—kidney cancer	1.23e-05	0.000356	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000352	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—kidney cancer	1.18e-05	0.000341	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—kidney cancer	1.15e-05	0.000334	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000334	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—kidney cancer	1.12e-05	0.000325	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JUN—kidney cancer	1.12e-05	0.000325	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—kidney cancer	1.11e-05	0.000322	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—kidney cancer	1.08e-05	0.000314	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CRABP1—kidney cancer	1.04e-05	0.000303	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—kidney cancer	9.78e-06	0.000284	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ITPR2—kidney cancer	9.71e-06	0.000282	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK3—kidney cancer	9.25e-06	0.000268	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—kidney cancer	9e-06	0.000261	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACHE—kidney cancer	8.86e-06	0.000257	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—kidney cancer	8.86e-06	0.000257	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK1—kidney cancer	8.8e-06	0.000255	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—POMC—kidney cancer	8.58e-06	0.000249	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SCARB1—kidney cancer	8.38e-06	0.000243	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—kidney cancer	8.31e-06	0.000241	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS1—kidney cancer	8.3e-06	0.000241	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMD7—kidney cancer	8.14e-06	0.000236	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BCHE—kidney cancer	7.71e-06	0.000224	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—kidney cancer	7.64e-06	0.000222	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.62e-06	0.000221	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—kidney cancer	7.39e-06	0.000214	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.36e-06	0.000213	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—kidney cancer	6.84e-06	0.000198	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—kidney cancer	6.14e-06	0.000178	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—kidney cancer	5.96e-06	0.000173	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCB1—kidney cancer	5.81e-06	0.000169	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—kidney cancer	5.64e-06	0.000164	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.35e-06	0.000155	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.21e-06	0.000122	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—POMC—kidney cancer	3.99e-06	0.000116	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—kidney cancer	3.18e-06	9.22e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—kidney cancer	2.77e-06	8.04e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.96e-06	5.67e-05	CbGpPWpGaD
